Catalyst Wire Dossier Catalyst Wire Dossier

ALN-AGT01 RVR

· Alnylam Pharmaceuticals
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ALN-AGT01 RVR, covering 2025-09-19 to 2025-09-19. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate ALN-AGT01 RVR in Adult Healthy Volunteers [Phase 1]

See pricing